The definition of chemical diabetes
dc.contributor.author | Fajans, Stefan S. | en_US |
dc.date.accessioned | 2006-04-17T16:42:41Z | |
dc.date.available | 2006-04-17T16:42:41Z | |
dc.date.issued | 1973-02 | en_US |
dc.identifier.citation | Fajans, Stefan S. (1973/02)."The definition of chemical diabetes." Metabolism 22(2, Part 2): 211-217. <http://hdl.handle.net/2027.42/33955> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WN4-4DCVKXG-2/2/99142f00e6c3be391659ca0032e65727 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/33955 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=4631671&dopt=citation | en_US |
dc.description.abstract | The natural history of diabetes mellitus can be arbitrarily divided into four stages based on the presence or absence of abnormal carbohydrate metabolism. Overt diabetes is the most advanced stage, characterized by elevated fasting blood glucose concentration and classical symptoms. This stage is divided into ketotic and nonketotic forms. Preceding overt diabetes is the latent or chemical diabetic stage, with no symptoms of diabetes but demonstrable abnormality of oral or intravenous glucose tolerance. Subclinical diabetes is an earlier stage when glucose tolerance is abnormal only with stress, such as pregnancy or the administration of cortisone. The earliest stage, prediabetes, extends from conception until the first demonstrable abnormality in glucose tolerance. In groups of presumed prediabetic individuals, delayed and/or decreased plasma insulin response to glucose has been noted. Progression of the diabetes may not occur, may occur very slowly or very rapidly, and regression to an earlier stage of abnormality may also occur. | en_US |
dc.format.extent | 486330 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | The definition of chemical diabetes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, (Division of Endocrinology and Metabolism and the Metabolism Research Unit), University of Michigan, Ann Arbor, Mich., USA | en_US |
dc.identifier.pmid | 4631671 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/33955/1/0000225.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0026-0495(73)90163-7 | en_US |
dc.identifier.source | Metabolism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.